相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The perivascular microenvironment in Epstein-Barr virus positive primary central nervous system lymphoma: The role of programmed cell death 1 and programmed cell death ligand 1
Yasuo Sugita et al.
NEUROPATHOLOGY (2018)
Blocking CTLA-4 while priming with a whole cell vaccine reshapes the oligoclonal T cell infiltrate and eradicates tumors in an orthotopic glioma model
Cameron S. Field et al.
ONCOIMMUNOLOGY (2018)
Nivolumab maintenance after salvage autologous stem cell transplantation results in long-term remission in multiple relapsed primary CNS lymphoma
Denis Terziev et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2018)
Engaging Natural Killer T Cells as 'Universal Helpers' for Vaccination
Mary Speir et al.
DRUGS (2017)
HLA class I-restricted MYD88 L265P-derived peptides as specific targets for lymphoma immunotherapy
Annika Nelde et al.
ONCOIMMUNOLOGY (2017)
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Ugur Sahin et al.
NATURE (2017)
Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma
Christian Grommes et al.
CANCER DISCOVERY (2017)
Glycolipid-peptide conjugate vaccines enhance CD8+ T cell responses against human viral proteins
M. Speir et al.
SCIENTIFIC REPORTS (2017)
Augmenting Influenza-Specific T Cell Memory Generation with a Natural Killer T Cell-Dependent Glycolipid-Peptide Vaccine
Regan J. Anderson et al.
ACS CHEMICAL BIOLOGY (2017)
PD-1 blockade with nivolumab in relapsed/refractory primary central nervous system and testicular lymphoma
Lakshmi Nayak et al.
BLOOD (2017)
Trends in primary central nervous system lymphoma incidence and survival in the US
Meredith S. Shiels et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Vaccine strategies for the treatment of lymphoma: preclinical progress and clinical trial update
Thomas U. Marron et al.
IMMUNOTHERAPY (2016)
Genome-Wide Analysis Uncovers Novel Recurrent Alterations in Primary Central Nervous System Lymphomas
Esteban Braggio et al.
CLINICAL CANCER RESEARCH (2015)
NKT cell-dependent glycolipid-peptide vaccines with potent anti-tumour activity
Regan J. Anderson et al.
CHEMICAL SCIENCE (2015)
An adjuvanted whole cell vaccine as post-remission immunotherapy for acute leukemia
Robert Weinkove et al.
ONCOIMMUNOLOGY (2015)
Dendritic cell vaccination combined with temozolomide retreatment: results of a phase I trial in patients with recurrent glioblastoma multiforme
Martin K. Hunn et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
An autologous leukemia cell vaccine prevents murine acute leukemia relapse after cytarabine treatment
John D. Gibbins et al.
BLOOD (2014)
Sustained Complete Responses in Patients With Lymphoma Receiving Autologous Cytotoxic T Lymphocytes Targeting Epstein-Barr Virus Latent Membrane Proteins
Catherine M. Bollard et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
A self-adjuvanting vaccine induces cytotoxic T lymphocytes that suppress allergy
Regan J. Anderson et al.
NATURE CHEMICAL BIOLOGY (2014)
A semisynthetic carbohydrate-lipid vaccine that protects against S-pneumoniae in mice
Marco Cavallari et al.
NATURE CHEMICAL BIOLOGY (2014)
Functional invariant natural killer T-cell and CD1d axis in chronic lymphocytic leukemia: implications for immunotherapy
Robert Weinkove et al.
HAEMATOLOGICA (2013)
Autologous CLL cell vaccination early after transplant induces leukemia-specific T cells
Ute E. Burkhardt et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
NKT cell adjuvant-based tumor vaccine for treatment of myc oncogene-driven mouse B-cell lymphoma
Stephen R. Mattarollo et al.
BLOOD (2012)
Vaccination with Irradiated Tumor Cells Pulsed with an Adjuvant That Stimulates NKT Cells Is an Effective Treatment for Glioma
Martin K. Hunn et al.
CLINICAL CANCER RESEARCH (2012)
Vaccination with dendritic cell/tumor fusion cells results in cellular and humoral antitumor immune responses in patients with multiple myeloma
Jacalyn Rosenblatt et al.
BLOOD (2011)
Immune adaptive microenvironment profiles in intracerebral and intrasplenic lymphomas share common characteristics
S. Donnou et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2011)
Harnessing invariant NKT cells in vaccination strategies
Vincenzo Cerundolo et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Invariant NKT cells promote CD8+ cytotoxic T cell responses by inducing CD70 expression on dendritic cells
Vadim Y. Taraban et al.
JOURNAL OF IMMUNOLOGY (2008)
Cross-presentation of glycolipid from tumor cells loaded with α-galactosylceramide leads to potent and long-lived T cell-mediated immunity via dendritic cells
Kanako Shimizu et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
An NKT mediated autologous vaccine generates CD4 T-cell-dependent potent antilymphoma immunity
Yeonseok Chung et al.
BLOOD (2007)
Tumor cells loaded with α-galactosylceramide induce innate NKT and NK cell-dependent resistance to tumor implantation in mice
Kanako Shimizu et al.
JOURNAL OF IMMUNOLOGY (2007)
Incidence and risk factors of central nervous system recurrence in aggressive lymphoma - a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)
V. Boehme et al.
ANNALS OF ONCOLOGY (2007)
Novel synthesis of α-galactosyl-ceramides and confirmation of their powerful NKT cell agonist activity
Adrianne Lee et al.
CARBOHYDRATE RESEARCH (2006)
Molecular mechanisms involved in T cell migration across the blood-brain barrier
B Engelhardt
JOURNAL OF NEURAL TRANSMISSION (2006)
The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation
SI Fujii et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Endogenous presentation of CD8+ T cell epitopes from Epstein-Barr virus-encoded nuclear antigen 1
J Tellam et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells
IF Hermans et al.
JOURNAL OF IMMUNOLOGY (2003)
Activation of natural killer T cells by α-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein
S Fujii et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Stressed apoptotic tumor cells stimulate dendritic cells and induce specific cytotoxic T cells
HP Feng et al.
BLOOD (2002)
Natural killer T cell ligand α-galactosylceramide enhances protective immunity induced by malaria vaccines
G Gonzalez-Aseguinolaza et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
分享论文
